Theriva Biologics (TOVX) Institutional Ownership $1.52 -0.03 (-1.94%) As of 04:10 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest Institutional Ownership Changes (13F Filings) for Theriva Biologics (NYSEAMERICAN:TOVX)CurrentInstitutional OwnershipPercentage6.17%Number ofInstitutional Buyers(last 12 months)1Number ofInstitutional Sellers(last 12 months)1 Get TOVX Insider Trade Alerts Want to know when executives and insiders are buying or selling Theriva Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Theriva Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Anson Funds Management LP139,046$192K0.0%N/A6.125% 11/15/2024 MSD Partners L.P.27,316$38K0.0%-95.4%1.203% (Data available from 1/1/2016 forward) TOVX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TOVX shares? During the previous two years, the following institutional investors and hedge funds held shares of Theriva Biologics shares: Anson Funds Management LP ($192K), MSD Partners L.P. ($38K).Learn more on TOVX's institutional investors. What percentage of Theriva Biologics stock is owned by institutional investors? 6.17% of Theriva Biologics stock is owned by institutional investors. Learn more on TOVX's institutional investor holdings. Which institutional investors have been buying Theriva Biologics stock? The following institutional investors have purchased Theriva Biologics stock in the last 24 months: Anson Funds Management LP ($139.05K). How much institutional buying is happening at Theriva Biologics? Institutional investors have bought a total of 139,046 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Theriva Biologics major shareholders have been selling company stock? The following institutional investors have sold Theriva Biologics stock in the last 24 months: MSD Partners L.P. ($571.10K). How much institutional selling is happening at Theriva Biologics? Institutional investors have sold a total of 571,095 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies GOVX Major Shareholders PHGE Major Shareholders NRSN Major Shareholders SYBX Major Shareholders DWTX Major Shareholders BMRA Major Shareholders EGRX Major Shareholders HCWB Major Shareholders MYNZ Major Shareholders CING Major Shareholders This page (NYSEAMERICAN:TOVX) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredA new coin is elbowing its way to the top of the crypto worldWith Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryA little-known IRS loophole has been gaining serious attention... If you have a retirement account, you can...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theriva Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theriva Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
